Analysis of magnetic resonance imaging features of ovarian thecoma

por Li, Zhi, Hu, Qingwei, Luo, Zhiqin, Deng, Zaixing, Zhou, Wei, Xie, Linghong
Publicado 2020

In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT(1A) Receptor Agonist for the Treatment of Schizophrenia

por Xiao, Guangqing, Chen, Yu-Luan, Dedic, Nina, Xie, Linghong, Koblan, Kenneth S., Galluppi, Gerald R.
Publicado 2022

Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia

por Heffernan, Michele L. R., Herman, Lee W., Brown, Scott, Jones, Philip G., Shao, Liming, Hewitt, Michael C., Campbell, John E., Dedic, Nina, Hopkins, Seth C., Koblan, Kenneth S., Xie, Linghong
Publicado 2021